HomePHARM • AMS
add
Pharming Group NV
Previous close
€1.05
Day range
€1.02 - €1.06
Year range
€0.65 - €1.10
Market cap
735.24M EUR
Avg Volume
9.24M
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 93.22M | 25.82% |
Operating expense | 81.20M | 17.29% |
Net income | 4.69M | 485.39% |
Net profit margin | 5.04 | 407.32% |
Earnings per share | 0.01 | 700.00% |
EBITDA | 5.75M | 591.12% |
Effective tax rate | 35.73% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 126.01M | -21.40% |
Total assets | 446.26M | 7.29% |
Total liabilities | 206.71M | 6.01% |
Total equity | 239.55M | — |
Shares outstanding | 667.62M | — |
Price to book | 2.92 | — |
Return on assets | 1.79% | — |
Return on capital | 2.17% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 4.69M | 485.39% |
Cash from operations | 11.74M | 188.82% |
Cash from investing | 16.96M | -53.41% |
Cash from financing | -2.76M | 90.26% |
Net change in cash | 32.00M | 773.64% |
Free cash flow | -1.77M | 84.84% |
About
Founded
1988
Website
Employees
404